Atropine / Hyoscyamine / Phenobarbital / Scopolamine Extended Release Oral Tablet

Brand(s)
Donnatal
Category(s)
prescription
SPL Type(s)
Human Prescription
Master SPL
Pbm Pharmaceuticals, Inc (2011-10-17)
Oldest Current Product
2008-05-07
License(s)
UNAPPROVED DRUG OTHER MARKETING CATEGORY
RxNORM
EXTENDED RELEASE ORAL TABLET\ATROPINE:HYOSCYAMINE:PHENOBARBITAL:SCOPOLAMINE
SPL Active
ORAL\TABLET, FILM COATED, EXTENDED RELEASE\ATROPINE SULFATE: HYOSCYAMINE SULFATE: PHENOBARBITAL: SCOPOLAMINE HYDROBROMIDE
SPL Moiety
ORAL\TABLET, FILM COATED, EXTENDED RELEASE\ATROPINE: HYOSCYAMINE: PHENOBARBITAL: SCOPOLAMINE

product(s) by strength(s)

atropine sulfate 0.0582 mg / hyoscyamine sulfate 0.311 mg / phenobarbital 48.6 mg / scopolamine hydrobromide 0.0195 mg extended release oral tablet

product(s)(s)

#idbrandcategorylabelerfirst marketedactive ingredient(s)routedose formspl
1662130421DonnatalUNAPPROVED DRUG OTHER MARKETING CATEGORYPbm Pharmaceuticals, Inc2008-05-07ATROPINE SULFATE, HYOSCYAMINE SULFATE, PHENOBARBITAL, SCOPOLAMINE HYDROBROMIDEORALTABLET, FILM COATED, EXTENDED RELEASE2064014b-6f8e-4232-88c2-d1870042abc7

spl(s)

#idtitlecategorytypelabelerlabeler actlast updateversionproduct(s)
12064014b-6f8e-4232-88c2-d1870042abc7 (view SPL)Donnatal ExtentabsprescriptionHuman PrescriptionPbm Pharmaceuticals, Incanalysis, label, manufacture, recovery, relabel, repack2011-10-171662130421

Data from: LOINC, MTHSPL, NDFRT, NCIT, RxNORM, UNII